Larry Robbins’ Glenview Capital is off to a very strong start this year.The health-care-driven hedge fund firm surged 9.4 percent in February, boosting its gains for the first two months to 16.3 percent, according to a person who has seen the numbers.Glenview declined to comment.The firm generally seeks out stocks